Anne-Marie Birkill

Brisbane’s MedTech sector is making a global impact. ProSeek Bio, founded by Michelle Hill, is developing blood tests to detect ovarian cancer and other conditions earlier – with less invasive methods. Michelle is part of our MedTech Global Accelerator Program, a Brisbane Economic Development Agency initiative backed by our Council. In just three years, the program has: ■ Helped 30 companies secure $246M in investment and create 250+ jobs ■ Built global connections for Brisbane innovators ■ Positioned Brisbane as one of the most investable cities in the Asia-Pacific These advances mean better health outcomes, new treatments and more opportunities – here in Brisbane and around the world. #MedTech #Innovation #HealthTech #Brisbane #GlobalLaunchpad

212

31 Comments

Seven local startups tackling the global dementia challenge will share in $15.7 million, thanks to CUREator+ Dementia & Cognitive Decline 🎉 Delivered by ANDHealth, Brandon BioCatalyst (Brandon Capital) and Dementia Australia with funding from the MRFF, CUREator+ supports the development and commercialisation of medical innovations focused on improving the lives of people impacted by dementia and cognitive decline globally. ANDHealth CEO Bronwyn Le Grice said, “By 2030, over 550,000 Australians will be living with dementia. These companies are at the forefront of Australian innovation, developing therapeutics, medical devices and digital and connected health solutions, which have the potential to profoundly improve the lives of people living with dementia and cognitive decline.” 💜 Redenlab: improving the detection and monitoring of cognitive decline in neurodegenerative disease by analysing subtle changes in language, speech and emotion. 💜 Perx Health: advancing its digital care management program with a 12-month pilot of a tailored dementia support app, developed with the aged care industry, to assist people living with dementia and their carers. 💜 Sydney Neuroimaging Analysis Centre (SNAC): advancing the development and clinical validation of its brain Magnetic Resonance Imaging (MRI) analysis tools. 💜 SynaptraBIO: supporting preclinical development and progression towards clinical trial of an orally bioavailable therapeutic for Alzheimer's Disease. 💜 Denteric Pty Ltd: advancing the clinical development of its vaccine candidate (GPV381) to treat Porphyromonas gingivalis (P. gingivalis) infection, which is hypothesised to play a crucial role in Alzheimer’s disease progression in infected patients 💜 Ceretas: enabling delivery of personalised therapeutic ultrasound to enhance connectivity and restore function in brain circuits affected in Alzheimer’s disease. 💜 Skin2Neuron: advancing the clinical development of its cell therapy to reverse Alzheimer’s disease by restoring lost neurons and synapses in the brain.

105

13 Comments

Ten breakthrough Brisbane companies are gearing up for global expansion and investment after being selected to join the city’s flagship MedTech Global Accelerator. From a blood test to detect early-stage ovarian cancer and world-first artificial heart, to cancer-fighting compounds found in Queensland rainforests, the early-stage companies are developing technologies with the potential to revolutionise global healthcare. Delivered by Brisbane Economic Development Agency in partnership with Life Science Nation, this six-month program offers tailored support to help companies scale and prepare for global markets – culminating in a high-profile investor pitch at J.P. Morgan Healthcare Week in San Francisco early next year. 👏 Congratulations to the 10 powerhouse businesses selected: aptium, BiVACOR, Cool Beans Underwear Pty Ltd, Fibrosoft, Ketim Technologies, Lorai Health, ProSeek Bio, QBiotics Group Limited, STARCO by QIMR Berghofer and Talius. We look forward to supporting your journey to bring lifesaving innovations to the world. Read more: https://lnkd.in/gcPJnvV9 Adrian Schrinner #ChooseBrisbane #LifeSciences Trade and Investment Queensland Department of State Development, Infrastructure and Planning

213

20 Comments

Australia's MedTech industry is thriving, and innovation is key. On this episode of Manufacturing Tech Australia, we sat down with Zeno Helm from SCHOTT MINIFAB to explore what makes Australia a global leader in medical device manufacturing. From navigating regulatory environments to fostering collaborative partnerships, Zeno shares valuable insights into developing and scaling innovative products. If you're in manufacturing, whether MedTech or beyond, this conversation is packed with takeaways you can apply immediately. 𝑳𝒊𝒔𝒕𝒆𝒏 𝒏𝒐𝒘 𝒂𝒏𝒅 𝒅𝒊𝒔𝒄𝒐𝒗𝒆𝒓 𝒉𝒐𝒘 𝒂𝒈𝒊𝒍𝒊𝒕𝒚 𝒂𝒏𝒅 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 𝒄𝒂𝒏 𝒅𝒓𝒊𝒗𝒆 𝒚𝒐𝒖𝒓 𝒎𝒂𝒏𝒖𝒇𝒂𝒄𝒕𝒖𝒓𝒊𝒏𝒈 𝒔𝒕𝒓𝒂𝒕𝒆𝒈𝒚.    https://lnkd.in/gMqCZBSE    Paul Mason * Anya Quenon  #MedTech #ManufacturingInnovation #AustralianManufacturing #Collaboration #MTApodcast 

62

A Brisbane-based startup linked to the co-founders of edtech unicorn Go1, one of whom is a doctor, is pioneering a new form of preventative health around the country and eventually the globe with a whole-of-body MRI scan solution designed for the early detection of more than 500 conditions. Co-founded in October last year by Go1 co-founders Dr Vu Tran and Andrew Barnes alongside entrepreneur and electrical engineer Gopi Sara, OneMRI has raised $2.5 million in seed capital to accelerate its expansion. The heavily oversubscribed round attracted investment from OIF Ventures, TEN13, Antler, Salus Ventures, AfterWork Ventures, Archangel Ventures, Black Sheep Capital, Prtnr, Larsen Ventures, Tribe Global Ventures, and a select group of clinicians and radiologists. https://lnkd.in/g47H_gun

29

2 Comments